|
|
| | L-Leucine, L-isoleucyl-L-prolyl-L-glutaminyl-L-seryl-L-leucyl-L-α-aspartyl-L-seryl-L-tryptophyl-L-tryptophyl-L-threonyl-L-seryl- Basic information |
| | L-Leucine, L-isoleucyl-L-prolyl-L-glutaminyl-L-seryl-L-leucyl-L-α-aspartyl-L-seryl-L-tryptophyl-L-tryptophyl-L-threonyl-L-seryl- Chemical Properties |
| Boiling point | 1851.0±65.0 °C(Predicted) | | density | 1.364±0.06 g/cm3(Predicted) | | pka | 3.30±0.10(Predicted) |
| | L-Leucine, L-isoleucyl-L-prolyl-L-glutaminyl-L-seryl-L-leucyl-L-α-aspartyl-L-seryl-L-tryptophyl-L-tryptophyl-L-threonyl-L-seryl- Usage And Synthesis |
| Uses | HBV Seq2 aa:28-39 is a HBsAg peptide, which binds to major histocompatibility complex (MHC) class I molecules[1][2]. | | References | [1] Ito H, et al. Induction of humoral and cellular immune response to HBV vaccine can be up-regulated by STING ligand. Virology. 2019 May;531:233-239. DOI:10.1016/j.virol.2019.03.013 [2] Ito H, et al. Induction of humoral and cellular immune response to hepatitis B virus (HBV) vaccine can be upregulated by CpG oligonucleotides complexed with Dectin-1 ligand. J Viral Hepat. 2017 Feb;24(2):155-162. DOI:10.1111/jvh.12629 |
| | L-Leucine, L-isoleucyl-L-prolyl-L-glutaminyl-L-seryl-L-leucyl-L-α-aspartyl-L-seryl-L-tryptophyl-L-tryptophyl-L-threonyl-L-seryl- Preparation Products And Raw materials |
|